tiprankstipranks
Advertisement
Advertisement

SNDX Stock Latest News

Syndax price target lowered to $31 from $34 at Guggenheim
The FlySyndax price target lowered to $31 from $34 at Guggenheim
9d ago
KURA
SNDX
Syndax Buy Rating Reiterated as Revuforj Data Strengthens AML Profile; $40 Price Target Maintained
PremiumRatings
Syndax Buy Rating Reiterated as Revuforj Data Strengthens AML Profile; $40 Price Target Maintained
9d ago
SNDX
Syndax presents data from SAVE trial at EHA
PremiumThe Fly
Syndax presents data from SAVE trial at EHA
10d ago
SNDX
Syndax Pharmaceuticals Reports New Significant Financial Obligation Agreement
PremiumCompany Announcements
Syndax Pharmaceuticals Reports New Significant Financial Obligation Agreement
10d ago
8K
SNDX
Syndax Shareholders Approve 2026 Equity and ESPP Plans
PremiumCompany Announcements
Syndax Shareholders Approve 2026 Equity and ESPP Plans
10d ago
8K
SNDX
Analyst Reiterates Buy on Syndax, Sees Durable Revuforj Upside with Unchanged $34 Price Target
PremiumRatingsAnalyst Reiterates Buy on Syndax, Sees Durable Revuforj Upside with Unchanged $34 Price Target
16d ago
SNDX
Syndax Pharmaceuticals Prices $250 Million Convertible Senior Notes
Premium
Company Announcements
Syndax Pharmaceuticals Prices $250 Million Convertible Senior Notes
17d ago
8K
SNDX
Syndax announces $250M convertible senior note offering due 2031
Premium
The Fly
Syndax announces $250M convertible senior note offering due 2031
17d ago
SNDX
Syndax price target lowered to $37 from $38 at UBS
PremiumThe Fly
Syndax price target lowered to $37 from $38 at UBS
1M ago
SNDX
Syndax reports 12 Revuforj abstracts accepted for EHA
PremiumThe Fly
Syndax reports 12 Revuforj abstracts accepted for EHA
1M ago
SNDX
Syndax price target raised to $46 from $45 at Stifel
PremiumThe Fly
Syndax price target raised to $46 from $45 at Stifel
2M ago
SNDX
Syndax price target lowered to $37 from $40 at Jefferies
PremiumThe Fly
Syndax price target lowered to $37 from $40 at Jefferies
2M ago
SNDX
Analyst Reiterates Buy on Syndax as Commercial Momentum Builds and Clinical Data Strengthens, Maintains $40 Price Target
PremiumRatingsAnalyst Reiterates Buy on Syndax as Commercial Momentum Builds and Clinical Data Strengthens, Maintains $40 Price Target
2M ago
SNDX
Syndax price target raised to $37 from $35 at Barclays
Premium
The Fly
Syndax price target raised to $37 from $35 at Barclays
2M ago
SNDX
Phil Nadeau Reiterates Buy on Syndax, Citing Strong Revuforj Momentum, Longer Treatment Durations, and Emerging Niktimvo Upside
Premium
Ratings
Phil Nadeau Reiterates Buy on Syndax, Citing Strong Revuforj Momentum, Longer Treatment Durations, and Emerging Niktimvo Upside
2M ago
SNDX
Syndax reports Q1 EPS (48c), consensus (59c)
PremiumThe Fly
Syndax reports Q1 EPS (48c), consensus (59c)
2M ago
SNDX
Syndax price target raised to $34 from $28 at Goldman Sachs
PremiumThe Fly
Syndax price target raised to $34 from $28 at Goldman Sachs
3M ago
SNDX
Syndax price target lowered to $43 from $45 at Mizuho
PremiumThe Fly
Syndax price target lowered to $43 from $45 at Mizuho
3M ago
SNDX
Syndax assumed with a Buy at Jefferies
PremiumThe Fly
Syndax assumed with a Buy at Jefferies
3M ago
KURA
SNDX
Syndax price target raised to $45 from $33 at JPMorgan
PremiumThe FlySyndax price target raised to $45 from $33 at JPMorgan
3M ago
SNDX
Syndax Pharmaceuticals’ Earnings Call Highlights Growth Push
Premium
Company Announcements
Syndax Pharmaceuticals’ Earnings Call Highlights Growth Push
4M ago
SNDX
Syndax price target raised to $57 from $51 at Citi
Premium
The Fly
Syndax price target raised to $57 from $51 at Citi
4M ago
SNDX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >